A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.


Akbulut O., Lengerli D., Saatci O., Duman E., Seker U., Isik A., ...More

Molecular cancer therapeutics, vol.19, pp.1243-1254, 2020 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19
  • Publication Date: 2020
  • Doi Number: 10.1158/1535-7163.mct-19-0957
  • Journal Name: Molecular cancer therapeutics
  • Journal Indexes: Science Citation Index Expanded, Scopus, PASCAL, Agricultural & Environmental Science Database, BIOSIS, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
  • Page Numbers: pp.1243-1254